Historical record - last NADAC effective date: 10/20/2021
Product Information
MEMANTINE HCL 10 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0968 per EA under NDC 53746016930. Its NADAC has been published 315 times since Oct 21, 2015.
FDA first approved this application on Apr 10, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
53746016930
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/20/2021
Active Ingredients
MEMANTINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090041FDA Approved
4/10/2015
TE Code
AB
On Market Since
4/30/2015
Pharmacological Classes
Price Statistics
The NADAC for MEMANTINE HCL 10 MG TABLET has been published 315 times since Oct 21, 2015, and over the history we have for it it has declined 72.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0968 per EA |
|---|---|
| All-time high | $0.3792 (Jan 13, 2016) |
| All-time low | $0.0849 (May 19, 2021) |
| Median price | $0.1181 |
| Average price | $0.1617 |
| Largest weekly change | -27.0% (Sep 23, 2020) |
| Weeks tracked | 315 |
| Tracking since | Oct 21, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+5.4%
All
-72.2%
Last surveyed Oct 27, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Memantine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
N-methyl-D-aspartate Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEMANTINE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE HCL 10 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0968 per EA (NDC 53746016930), effective Oct 27, 2021.
How has the price of MEMANTINE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEMANTINE HCL 10 MG TABLET has declined 72.2%. It has been tracked across 315 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for MEMANTINE HCL 10 MG TABLET?
Since Oct 21, 2015, the NADAC for MEMANTINE HCL 10 MG TABLET has ranged from a low of $0.0849 (May 19, 2021) to a high of $0.3792 (Jan 13, 2016), with a median of $0.1181 per EA.
Are there cheaper alternatives to MEMANTINE HCL 10 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEMANTINE HCL 10 MG TABLET, is $0.0630 per EA — about 35% below MEMANTINE HCL 10 MG TABLET.
Who manufactures MEMANTINE HCL 10 MG TABLET?
MEMANTINE HCL 10 MG TABLET (NDC 53746016930) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.